143 related articles for article (PubMed ID: 21291405)
1. SHP-1 in cell-cycle regulation.
López-Ruiz P; Rodriguez-Ubreva J; Cariaga AE; Cortes MA; Colás B
Anticancer Agents Med Chem; 2011 Jan; 11(1):89-98. PubMed ID: 21291405
[TBL] [Abstract][Full Text] [Related]
2. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
4. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.
Tibaldi E; Zonta F; Bordin L; Magrin E; Gringeri E; Cillo U; Idotta G; Pagano MA; Brunati AM
Biochim Biophys Acta; 2014 Feb; 1843(2):288-98. PubMed ID: 24140598
[TBL] [Abstract][Full Text] [Related]
6. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.
Lorenz U
Immunol Rev; 2009 Mar; 228(1):342-59. PubMed ID: 19290938
[TBL] [Abstract][Full Text] [Related]
7. Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs).
Irandoust M; van den Berg TK; Kaspers GJ; Cloos J
Anticancer Agents Med Chem; 2009 Feb; 9(2):212-20. PubMed ID: 19199865
[TBL] [Abstract][Full Text] [Related]
8. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
9. Activation of Cdk2 stimulates proteasome-dependent truncation of tyrosine phosphatase SHP-1 in human proliferating intestinal epithelial cells.
Simoneau M; Boulanger J; Coulombe G; Renaud MA; Duchesne C; Rivard N
J Biol Chem; 2008 Sep; 283(37):25544-25556. PubMed ID: 18617527
[TBL] [Abstract][Full Text] [Related]
10. Regulation of peripheral and central immunity: Understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2.
Garg M; Wahid M; Khan F
Immunobiology; 2020 Jan; 225(1):151847. PubMed ID: 31561841
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
Tassidis H; Brokken LJ; Jirström K; Ehrnström R; Pontén F; Ulmert D; Bjartell A; Härkönen P; Wingren AG
Int J Cancer; 2010 May; 126(10):2296-307. PubMed ID: 19795453
[TBL] [Abstract][Full Text] [Related]
12. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
Su MW; Yu CL; Burakoff SJ; Jin YJ
J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
[TBL] [Abstract][Full Text] [Related]
13. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
14. An extract of Perilla stem inhibits Src homology phosphatase-1 (SHP)-1 and influences insulin signaling.
Peng L; Lei Z; Xiao-na X; Deli W; Jing S; Yong-sen W; Zhi W; Shu X; Jun-feng M; Wan-nan L; Xue-qi F
Pak J Pharm Sci; 2015 Mar; 28(2):421-4. PubMed ID: 25730798
[TBL] [Abstract][Full Text] [Related]
15. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
17. Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways.
Sharma Y; Ahmad A; Bashir S; Elahi A; Khan F
Future Oncol; 2016 May; 12(10):1287-98. PubMed ID: 26987952
[TBL] [Abstract][Full Text] [Related]
18. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases.
Lee JH; Chiang SY; Nam D; Chung WS; Lee J; Na YS; Sethi G; Ahn KS
Cancer Lett; 2014 Apr; 345(1):140-8. PubMed ID: 24333736
[TBL] [Abstract][Full Text] [Related]
19. Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.
Huang TT; Su JC; Liu CY; Shiau CW; Chen KF
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594363
[TBL] [Abstract][Full Text] [Related]
20. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]